Journal Menu
► ▼ Journal Menu-
- Molecules Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
- 30th Anniversary
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Vol. 31 (2026)
- Vol. 30 (2025)
- Vol. 29 (2024)
- Vol. 28 (2023)
- Vol. 27 (2022)
- Vol. 26 (2021)
- Vol. 25 (2020)
- Vol. 24 (2019)
- Vol. 23 (2018)
- Vol. 22 (2017)
- Vol. 21 (2016)
- Vol. 20 (2015)
- Vol. 19 (2014)
- Vol. 18 (2013)
- Vol. 17 (2012)
- Vol. 16 (2011)
- Vol. 15 (2010)
- Vol. 14 (2009)
- Vol. 13 (2008)
- Vol. 12 (2007)
- Vol. 11 (2006)
- Vol. 10 (2005)
- Vol. 9 (2004)
- Vol. 8 (2003)
- Vol. 7 (2002)
- Vol. 6 (2001)
- Vol. 5 (2000)
- Vol. 4 (1999)
- Vol. 3 (1998)
- Vol. 2 (1997)
- Volumes not published by MDPI
Need Help?
Conferences
15–17 May 2019, Barcelona, Spain
2nd Molecules Medicinal Chemistry Symposium – Facing Novel Challenges in Drug Discovery
It is with great pleasure that I announce the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery to be held in Barcelona, Spain, 15–17 May 2019.
Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 will grow naturally by addressing a larger audience and essentially all topics of medicinal chemistry. The MMCS2019 will be organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.
